82 related articles for article (PubMed ID: 12722282)
1. [Aspergillosis].
Mori T
Nihon Rinsho; 2003 Feb; 61 Suppl 2():571-5. PubMed ID: 12722282
[No Abstract] [Full Text] [Related]
2. [Candidiasis].
Maesaki S; Yamaguchi T
Nihon Rinsho; 2003 Feb; 61 Suppl 2():564-70. PubMed ID: 12722281
[No Abstract] [Full Text] [Related]
3. Efficacy of voriconazole plus amphotericin B or micafungin in a guinea-pig model of invasive pulmonary aspergillosis.
Chandrasekar PH; Cutright JL; Manavathu EK
Clin Microbiol Infect; 2004 Oct; 10(10):925-8. PubMed ID: 15373889
[TBL] [Abstract][Full Text] [Related]
4. Combination antifungal therapy of murine aspergillosis: liposomal amphotericin B and micafungin.
Graybill JR; Bocanegra R; Gonzalez GM; Najvar LK
J Antimicrob Chemother; 2003 Oct; 52(4):656-62. PubMed ID: 12972452
[TBL] [Abstract][Full Text] [Related]
5. Caspofungin versus liposomal amphotericin B for empirical therapy.
Marty FM; Lowry CM
N Engl J Med; 2005 Jan; 352(4):410-4; author reply 410-4. PubMed ID: 15675093
[No Abstract] [Full Text] [Related]
6. Early diagnosis and successful management of atypical invasive Aspergillus sinusitis in a hematopoietic cell transplant patient: a case report.
Myoken Y; Sugata T; Fujita Y; Fujihara M; Iwato K; Murayama SY; Mikami Y
J Oral Maxillofac Surg; 2006 May; 64(5):860-3. PubMed ID: 16631499
[No Abstract] [Full Text] [Related]
7. Successful medical treatment of cutaneous aspergillosis in a premature infant using liposomal amphotericin B, voriconazole and micafungin.
Santos RP; Sánchez PJ; Mejias A; Benjamin DK; Walsh TJ; Patel S; Jafri HS
Pediatr Infect Dis J; 2007 Apr; 26(4):364-6. PubMed ID: 17414408
[TBL] [Abstract][Full Text] [Related]
8. Steady-state pharmacokinetics of micafungin and voriconazole after separate and concomitant dosing in healthy adults.
Keirns J; Sawamoto T; Holum M; Buell D; Wisemandle W; Alak A
Antimicrob Agents Chemother; 2007 Feb; 51(2):787-90. PubMed ID: 17116670
[TBL] [Abstract][Full Text] [Related]
9. Cerebral aspergillosis in the critically ill: two cases of successful medical treatment.
Ehrmann S; Bastides F; Gissot V; Mercier E; Magro P; Bailly E; Legras A
Intensive Care Med; 2005 May; 31(5):738-42. PubMed ID: 15782314
[TBL] [Abstract][Full Text] [Related]
10. Update on antifungal drug resistance mechanisms of Aspergillus fumigatus.
Chamilos G; Kontoyiannis DP
Drug Resist Updat; 2005 Dec; 8(6):344-58. PubMed ID: 16488654
[TBL] [Abstract][Full Text] [Related]
11. [Clinical development of antimycotics. Medical challenges].
Lipp HP
Pharm Unserer Zeit; 2003; 32(2):144-52. PubMed ID: 12677968
[No Abstract] [Full Text] [Related]
12. Effect of amphotericin B and micafungin combination on survival, histopathology, and fungal burden in experimental aspergillosis in the p47phox-/- mouse model of chronic granulomatous disease.
Dennis CG; Greco WR; Brun Y; Youn R; Slocum HK; Bernacki RJ; Lewis R; Wiederhold N; Holland SM; Petraitiene R; Walsh TJ; Segal BH
Antimicrob Agents Chemother; 2006 Feb; 50(2):422-7. PubMed ID: 16436692
[TBL] [Abstract][Full Text] [Related]
13. Activity of micafungin (FK463) against an itraconazole-resistant strain of Aspergillus fumigatus and a strain of Aspergillus terreus demonstrating in vivo resistance to amphotericin B.
Warn PA; Morrissey G; Morrissey J; Denning DW
J Antimicrob Chemother; 2003 Apr; 51(4):913-9. PubMed ID: 12654746
[TBL] [Abstract][Full Text] [Related]
14. Cerebral aspergillosis diagnosed by detection of Aspergillus flavus-specific DNA, galactomannan and (1-->3)-beta-D-glucan in clinical specimens.
Khan ZU; Ahmad S; Mokaddas E; Said T; Nair MP; Halim MA; Nampoory MR; McGinnis MR
J Med Microbiol; 2007 Jan; 56(Pt 1):129-132. PubMed ID: 17172527
[TBL] [Abstract][Full Text] [Related]
15. [Micafungin therapy for a case of chronic necrotizing pulmonary aspergillosis].
Sugino Y; Fujii M; Kato M; Yagi A; Kawabata A
Nihon Kokyuki Gakkai Zasshi; 2006 Jun; 44(6):458-63. PubMed ID: 16841718
[TBL] [Abstract][Full Text] [Related]
16. Sequential or combination antifungal therapy with voriconazole and liposomal amphotericin B in a Guinea pig model of invasive aspergillosis.
Kirkpatrick WR; Coco BJ; Patterson TF
Antimicrob Agents Chemother; 2006 Apr; 50(4):1567-9. PubMed ID: 16569887
[TBL] [Abstract][Full Text] [Related]
17. Current approaches to management of cerebral fungal infection in pediatric patients with hematologic disorders.
Sato T; Kaneda M; Ichikawa M; Suzuki D; Nakagawa A; Kobayashi R
J Pediatr Hematol Oncol; 2008 Mar; 30(3):249-53. PubMed ID: 18376292
[TBL] [Abstract][Full Text] [Related]
18. [Combination therapy of micafungin and itraconazole for a case of pulmonary aspergillosis].
Maruyama T; Takagi T; Yuda H
Nihon Kokyuki Gakkai Zasshi; 2005 Feb; 43(2):94-8. PubMed ID: 15770940
[TBL] [Abstract][Full Text] [Related]
19. Successful treatment with micafungin of invasive pulmonary aspergillosis in acute myeloid leukemia, with renal failure due to amphotericin B therapy.
Yokote T; Akioka T; Oka S; Fujisaka T; Yamano T; Hara S; Tsuji M; Hanafusa T
Ann Hematol; 2004 Jan; 83(1):64-6. PubMed ID: 14661114
[TBL] [Abstract][Full Text] [Related]
20. [The future of antifungal agents].
Maesaki S
Rinsho Ketsueki; 2007 Jan; 48(1):26-35. PubMed ID: 17313074
[No Abstract] [Full Text] [Related]
[Next] [New Search]
